Clinical Trial: Preliminary exploratory clinical study on efficacy, safety and radiation dosimetry of^177Lu-LNC1009 injection in FAPI-RGD positive RAIR-DTC patients (China)

Posted On: 2026-08-11

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Preliminary exploratory clinical study on efficacy, safety and radiation dosimetry of^177Lu-LNC1009 injection in FAPI-RGD positive RAIR-DTC patients'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129507

Registration Time: 2026/08/05

Type: Interventional study

Primary Sponsor: Peking Union Medical College Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=327456

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

Clinical Trial: Preliminary exploratory clinical study on efficacy, safety and radiation dosimetry of^177Lu-LNC1009 injection in FAPI-RGD positive RAIR-DTC patients (China)